In this context, liver cancer cell growth is stimulated by exposure to AREG (Figure 5), while this effect is abrogated by the simultaneous addition of a neutralizing anti-AREG antibody, implying that the estrogen-induced rise of AREG expression and/or activity may ultimately lead to a significant increase of cell proliferation [54]. The gene discussed is AREG; the disease is liver cancer.